loader
Please Wait
Applying Filters...
menu
    • menu

    Generics: HUMIRA® REMICADE® (adalimumab ; infliximab): AbbVie Inc. et al v. Boehringer Ingelheim International GMBH - Abbvie Contract Manufacturing

    MenuAbbvie Contract Manufacturing

    Uploaded: 2022
    News
    Success Factors for Pre-Filled Syringe CMO Selection

    15 Jul 2024

    // PRESS RELEASE

    AbbVie Preps Global Parenteral Sites For Annex 1 Compliance Requirements

    24 Jun 2024

    // PRESS RELEASE

    Translating Environmental, Social and Governance (ESG) Benefits to our Partners

    10 May 2024

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    AbbVie Contract Manufacturing

    Contact Supplier

    Website

    DCAT Week

    InterContinental NY Barclay

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.youtube.com/embed/z4lt1f6ZXL4
    Xls

    CATEGORY PAGE
    Menu

    Abbvie Contract Manufacturing

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    SERVICES

    Key Services KEY SERVICES

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    PI73093
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.